FIELD: pharmacology.
SUBSTANCE: invention is a transdermal delivery composition comprising non-covalent complexes between non-sulphated chondroitin having a molecular weight of 5 to 100 kDa determined by exclusion chromatography and active ingredients selected from diclofenac or its salts and ketorolac or its salts.
EFFECT: invention provides passage through the stratum corneum of the skin, penetration into the epidermis, through the mucous membrane, as well as delayed release of the active components.
4 cl, 11 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHONDROITIN FOR APPLICATION IN MEDICINE | 2013 |
|
RU2642964C2 |
| WOUND COAT BASED ON COLLAGEN-CHITOSAN COMPLEX | 2003 |
|
RU2254145C1 |
| ABSORBENT DRESSINGS WITH PAINKILLING ACTIVITY | 2012 |
|
RU2581914C2 |
| METHOD OF POLYSACCHARIDES CROSS-LINKING USING PHOTO-SELECTABLE PROTECTIVE GROUPS | 2016 |
|
RU2713295C2 |
| METHOD FOR PREVENTION OF ULTRA CASING ON GASTRIC MUCOSA | 2021 |
|
RU2759575C1 |
| METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
| COMPOSITION FOR INSTILLATION OF URINARY BLADDER WITH INCREASED STABILITY DURING STORAGE, CONTAINING CHONDROITIN SULPHATE (4_5 MG/ML), HYALURONIC ACID (16 MG/ML) AND PHOSPHATE BUFFER (PH 6_1-7_9), FOR TREATING CYSTITIS | 2018 |
|
RU2742277C1 |
| COMPOSITIONS CONTAINING POLYSACCHARIDE MATRIX FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS | 2017 |
|
RU2748261C2 |
| SULPHATED POLYSACCHARIDES DERIVATIVES, THEIR PRODUCTION METHOD, MODIFICATION AND APPLICATION | 2016 |
|
RU2708327C2 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
